Carlsmed, Inc. CARL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 65.39% | 74.90% | 85.94% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.39% | 74.90% | 85.94% | -- | -- |
| Cost of Revenue | 48.78% | 65.00% | 75.23% | -- | -- |
| Gross Profit | 71.22% | 78.31% | 89.74% | -- | -- |
| SG&A Expenses | 71.33% | 68.68% | 72.75% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.93% | 59.51% | 58.10% | -- | -- |
| Operating Income | -56.57% | -39.24% | -26.75% | -- | -- |
| Income Before Tax | -45.22% | -32.85% | -22.17% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.22% | -32.85% | -22.17% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.22% | -32.85% | -22.17% | -- | -- |
| EBIT | -56.57% | -39.24% | -26.75% | -- | -- |
| EBITDA | -55.99% | -38.68% | -26.34% | -- | -- |
| EPS Basic | 76.58% | 59.36% | 39.93% | -- | -- |
| Normalized Basic EPS | 75.45% | 57.43% | 40.75% | -- | -- |
| EPS Diluted | 76.58% | 59.36% | 39.93% | -- | -- |
| Normalized Diluted EPS | 75.45% | 57.43% | 40.75% | -- | -- |
| Average Basic Shares Outstanding | 494.60% | 377.44% | 247.78% | -- | -- |
| Average Diluted Shares Outstanding | 494.60% | 377.44% | 247.78% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |